BioNTech Se v. CureVac Ag

Court

District Court, D. Massachusetts (D. Mass.)
Official Court Website →

Assigned judge

Nathaniel M. Gorton · 3,922 cases in index

Docket number

1:22-cv-11202

Cause

28:2201 Declaratory Judgment
28 U.S.C. § 2201 — Declaratory judgment

Nature of suit

830 Patent
Infringement of a patented invention.

Jurisdiction

Federal Question

Jury demand

Plaintiff

Date filed

07/25/2022

Date terminated

05/16/2023

2,287 Patent cases in this court are indexed here.

Parties

• plaintiff · BioNTech Se Pharmaceuticals & Biotechnology · 5 cases
• defendant · CureVac Ag

About Patent Lawsuits

Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

Frequently Asked Questions

What is BioNTech Se v. CureVac Ag?

BioNTech Se v. CureVac Ag is a federal patent lawsuit filed on 07/25/2022 in the District Court, D. Massachusetts. The case was terminated on 05/16/2023. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

What type of case is this?

It is classified as “Patent” under the federal nature-of-suit system. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

What court is the case in?

The case is in the District Court, D. Massachusetts, docket number 1:22-cv-11202.

When was the case filed?

BioNTech Se v. CureVac Ag was filed on 07/25/2022. It was terminated on 05/16/2023.

What law is the case brought under?

The docket lists the cause as 28 U.S.C. § 2201 — Declaratory judgment.